Related Experiment Video

Updated: Mar 26, 2026

Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

3.3K

The Mechanism by Which MYCN Amplification Confers an Enhanced Sensitivity to a PCNA-Derived Cell Permeable Peptide in

Long Gu1, Peiguo Chu2, Robert Lingeman1

  • 1Department of Molecular & Cellular Biology, Beckman Research Institute, City of Hope, Duarte, CA 91010, United States of America.

Ebiomedicine
|February 5, 2016
PubMed

Insights

A novel peptide, R9-caPep, targets MYC-driven neuroblastoma by disrupting DNA replication. This peptide selectively kills cancer cells with MYCN amplification, offering a new therapeutic strategy for high-risk neuroblastoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Dysregulated MYC gene family expression is common in malignancies.
  • MYC proteins are challenging therapeutic targets for small molecule or protein-based agents.
  • MYCN amplification is a marker for high-risk neuroblastoma (NB).

Purpose of the Study:

  • To elucidate the mechanism by which R9-caPep selectively kills MYCN-amplified neuroblastoma cells.
  • To investigate the impact of R9-caPep on DNA replication stress in MYCN-amplified NB cells.

Main Methods:

  • Investigated the effect of R9-caPep on DNA replication stress in MYCN-amplified NB cells.
  • Assessed the role of DNA replication fork extension interference and Chk1 dependence in R9-caPep's mechanism.
  • Evaluated the susceptibility of NB cells to Chk1 inhibition following R9-caPep treatment.

Main Results:

  • MYCN-amplified NB cells exhibit elevated DNA replication stress.
  • R9-caPep intensifies DNA replication stress in MYCN-amplified NB cells and those with increased MYC levels.
  • R9-caPep treatment leads to Chk1 dependence and increased sensitivity to Chk1 inhibitors.

Conclusions:

  • R9-caPep effectively targets MYCN-amplified neuroblastoma by exacerbating DNA replication stress.
  • The mechanism involves interference with DNA replication fork extension, creating Chk1 dependence.
  • These findings suggest a potential therapeutic strategy for treating neuroblastoma by combining R9-caPep with Chk1 inhibitors.
Keywords:
Chk1DNA damage responseMYCMYCNNeuroblastomaProliferating Cell Nuclear Antigen (PCNA)Replication stress

More Related Videos

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis09:45

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis

Published on: March 31, 2015

11.8K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K